BG Medicine, Inc.
BGMD · OTC
12/31/2015 | 12/31/2014 | 12/31/2013 | 12/31/2012 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -43.8% | -31.6% | 44.7% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 67.8% | 65.7% | 65.9% | 66% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -322.9% | -258.5% | -362.3% | -796.2% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -338.6% | -289.3% | -389.1% | -844.4% |
| EPS Diluted | -0.55 | -0.99 | -2.33 | -4.7 |
| % Growth | 44.4% | 57.5% | 50.4% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | $0 | $0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |